208 related articles for article (PubMed ID: 2884877)
1. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
2. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
[TBL] [Abstract][Full Text] [Related]
3. The glucagonoma syndrome: a review of its features and discussion of new perspectives.
Chastain MA
Am J Med Sci; 2001 May; 321(5):306-20. PubMed ID: 11370794
[TBL] [Abstract][Full Text] [Related]
4. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
Kitoh M; Ohyama K; Shigeo ; Arao AT
Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
[No Abstract] [Full Text] [Related]
5. [Glucagonoma: evolution and treatment].
Carvajal C; Azabache V; Lobos P; Ibarra A
Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
[TBL] [Abstract][Full Text] [Related]
6. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
[TBL] [Abstract][Full Text] [Related]
7. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
Povoski SP; Zaman SA; Ducatman BS; McFadden DW
W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
[TBL] [Abstract][Full Text] [Related]
8. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
Kindmark H; Sundin A; Granberg D; Dunder K; Skogseid B; Janson ET; Welin S; Oberg K; Eriksson B
Med Oncol; 2007; 24(3):330-7. PubMed ID: 17873310
[TBL] [Abstract][Full Text] [Related]
9. The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
Wermers RA; Fatourechi V; Wynne AG; Kvols LK; Lloyd RV
Medicine (Baltimore); 1996 Mar; 75(2):53-63. PubMed ID: 8606627
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.
Santangelo WC; Unger RH; Orci L; Dueno MI; Popma JJ; Krejs GJ
Pancreas; 1986; 1(5):464-9. PubMed ID: 2882503
[TBL] [Abstract][Full Text] [Related]
11. Glucagonoma without cutaneous manifestations.
Parr JH; Ramsay ID; Keeling PW; Thompson RP; Mallinson CN
Postgrad Med J; 1985 Aug; 61(718):737-8. PubMed ID: 2994032
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous and oral changes as the only manifestations of the glucagonoma syndrome.
Ditty JF; Lang PG
South Med J; 1982 Feb; 75(2):222-4. PubMed ID: 6277014
[No Abstract] [Full Text] [Related]
13. [The glucagonomas (author's transl)].
Luyckx AS; Lefebvre PJ
Diabete Metab; 1981 Dec; 7(4):289-300. PubMed ID: 6120860
[No Abstract] [Full Text] [Related]
14. Glucagonoma tumors and syndrome.
Montenegro-Rodas F; Samaan NA
Curr Probl Cancer; 1981 Dec; 6(6):1-54. PubMed ID: 6276079
[No Abstract] [Full Text] [Related]
15. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
Saavedra C; Lamarca A; Hubner RA
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
[TBL] [Abstract][Full Text] [Related]
16. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
17. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
18. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
[No Abstract] [Full Text] [Related]
19. The glucagonoma syndrome: clinical features, diagnosis, and treatment.
Stacpoole PW
Endocr Rev; 1981; 2(3):347-61. PubMed ID: 6268399
[No Abstract] [Full Text] [Related]
20. Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome.
Kahan RS; Perez-Figaredo RA; Neimanis A
Arch Dermatol; 1977 Jun; 113(6):792-7. PubMed ID: 194537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
